A  Partial List Of Current Scientific Review Articles On CBD

Note: These articles can be found on PubMed, the US National Library of Medicine’s database. PubMed is free and open to the general public around the world as well as to the scientific community. Searches and summaries of articles (abstracts) are always free.  Some of the articles also have free full text and are marked as such. The site is at: https://pubmed.ncbi.nlm.nih.gov/. Articles are initially sorted by best match, just like Google. To choose how articles are sorted (for example by date) click on the Display Options box and choose from several options. To get a summary of the article, click on the short cititation. You can also go directly to the article summary in PubMed by typing the string of letters and numbers that follow “doi:” in the list below. Links have been added to Pubmed or the publisher’s websites for the articles.

This list was created in the summer of 2020. There may be more recent research also.

Return to FAQ

Pain and Inflammation

Svensson CK. CBD for the treatment of pain: What is the evidence? [published online ahead of print, 2020 Jul 4]. J Am Pharm Assoc (2003). 2020;S1544-3191(20)30275-2. doi:10.1016/j.japh.2020.06.009.

Boyaji S, Merkow J, Elman RNM, Kaye AD, Yong RJ, Urman RD. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence. Curr Pain Headache Rep. 2020;24(2):4. Published 2020 Jan 24. doi:10.1007/s11916-020-0835-4.

Xu DH, Cullen BD, Tang M, Fang Y. The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. Curr Pharm Biotechnol. 2020;21(5):390-402. doi:10.2174/1389201020666191202111534.

Argueta DA, Ventura CM, Kiven S, Sagi V, Gupta K. A Balanced Approach for Cannabidiol Use in Chronic Pain. Front Pharmacol. 2020;11:561. Published 2020 Apr 30. doi:10.3389/fphar.2020.00561.

Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pain Physician 2017:Sep;20(6):E755-E796.

Baron EP. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache 2018 Jul;58(7):1139-1186. doi: 10.1111/head.13345.

Arthritis

Fitzcharles MA, Clauw DJ, Hauser W. A cautious hope for cannabidiol (CBD) in rheumatology care [published online ahead of print, 2020 Mar 7]. Arthritis Care Res (Hoboken). 2020;10.1002/acr.24176. doi:10.1002/acr.24176.

Anxiety

Skelley JW, Deas CM, Curren Z, Ennis J. Use of cannabidiol in anxiety and anxiety-related disorders. J Am Pharm Assoc (2003). 2020;60(1):253-261. doi:10.1016/j.japh.2019.11.008.

Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825-836. doi:10.1007/s13311-015-0387-1.

Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series. Perm J. 2019;23:18-041. doi:10.7812/TPP/18-041.

lms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. J Altern Complement Med. 2019;25(4):392-397. doi:10.1089/acm.2018.0437.

Sleep

Kuhathasan N, Dufort A, MacKillop J, Gottschalk R, Minuzzi L, Frey BN. The use of cannabinoids for sleep: A critical review on clinical trials. Exp Clin Psychopharmacol. 2019;27(4):383-401. doi:10.1037/pha0000285.

Nausea

Taylor B, Mueller M, Sauls R. Cannaboinoid Antiemetic Therapy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 24, 2019, updated 9/12/20.

Fighting Cancer

Afrin F, Chi M, Eamens AL, et al. Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer. Cancers (Basel). 2020;12(4):1033. Published 2020 Apr 23. doi:10.3390/cancers12041033.

Inflammatory Bowel Disease and Gastrointestinal Health

Martínez V, Iriondo De-Hond A, Borrelli F, Capasso R, Del Castillo MD, Abalo R. Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?. Int J Mol Sci. 2020;21(9):3067. Published 2020 Apr 26. doi:10.3390/ijms21093067.

Psoriasis And Other Dermatological Conditions

Palmieri B, Laurino C, Vadalà M. A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. Clin Ter. 2019;170(2):e93-e99. doi:10.7417/CT.2019.2116.

Balancing The Immune System

Nichols JM, Kaplan BLF. Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res. 2020;5(1):12-31. Published 2020 Feb 27. doi:10.1089/can.2018.0073.

Multiple Sclerosis

Nielsen S, Germanos R, Weier M, et al. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews. Curr Neurol Neurosci Rep. 2018;18(2):8. Published 2018 Feb 13. doi:10.1007/s11910-018-0814-x.

Controlling Epileptic Seizures and Other Neurological Disorders

Wijnen B, Armstrong N, Ramaekers B, et al. Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 2020;38:1043–1053. doi:10.1007/s40273-020-00932-4.

Arzimanoglou A, Brandl U, Cross JH, et al. Epilepsy and cannabidiol: a guide to treatment. Epileptic Disord. 2020;22(1):1-14. doi:10.1684/epd.2020.1141.

Alzheimer’s Disease and Other Forms of Dementia

Mueller A, Fixen DR. Use of Cannabis for Agitation in Patients With Dementia. Sr Care Pharm. 2020;35(7):312-317. doi:10.4140/TCP.n.2020.312.

Recovery from Drug Addiction

Rodrigues LA, Caroba MES, Taba FK, Filev R, Gallassi AD. Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review. Pharmacol Biochem Behav. 2020;196:172982. doi:10.1016/j.pbb.2020.172982.

Schizophrenia and Psychotic Disorders

Schoevers J, Leweke JE, Leweke FM. Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies. Curr Opin Psychiatry. 2020;33(3):185-191. doi:10.1097/YCO.0000000000000596.

Luján MÁ, Valverde O. The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders. Front Behav Neurosci. 2020;14:109. Published 2020 Jun 26. doi:10.3389/fnbeh.2020.00109.

Kopelli E, Samara M, Siargkas A, Goulas A, Papazisis G, Chourdakis M. The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis. Psychiatry Res. 2020;291:113246. doi:10.1016/j.psychres.2020.113246.

Ghabrash MF, Coronado-Montoya S, Aoun J, et al. Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment [published online ahead of print, 2020 Feb 21]. Psychiatry Res. 2020;286:112890. doi:10.1016/j.psychres.2020.112890.

Return to FAQ